You are here: Industry Insights > oncology

News List

Thermo Fisher Expands GlobalAccess Program to Oncology Labs americanpharmaceuticalreview
August 03, 2020
Thermo Fisher Scientific has announced the expansion of its GlobalAccess Sequencing Program to include laboratories working in oncology.
Merck Inks $425M Oncology Deal with Foghorn Therapeutics contractpharma
July 09, 2020
To discover and develop novel oncology therapeutics against transcription factor target.
FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials worldpharmanews
June 29, 2020
The U.S. Food and Drug Administration launched Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence (OCE).
AbbVie and Genmab link for oncology collaboration pharmatimes
June 16, 2020
AbbVie and Genmab have signed a pact to jointly develop and commercialise three of the latter's early-stage investigational bispecific antibody product candidates ...
Thermo Fisher, Agios Pharma to Co-develop Oncology CDx contractpharma
June 10, 2020
To identify IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new sequencing solution.
Enhertu granted orphan drug designation in US for gastric cancer pharmaceutical-business-review
May 28, 2020
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Orphan Drug Designation (ODD) in the US for the treatment of patients with gastric cancer, including gastroesophageal junction cancer.
75 percent of nanopharmaceuticals are being developed for oncology europeanpharmaceuticalreview
April 09, 2020
A report states that three quarters of the roughly 230 nanopharmaceuticals in clinical development are for use as targeted cancer therapeutics.
Innovent, Alector Enter Oncology Alliance contractpharma
April 01, 2020
To develop and commercialize an anti-SIRP-alpha antibody (Alector's AL008) for the treatment of oncology indications in China.
Insight into 2020’s clinical trials landscape europeanpharmaceuticalreview
March 11, 2020
Oncology, industry-sponsored and a combination of the two, will account for the majority of clinical trials categories over the course of the coming year.
Ten drugs in pre-registration likely to be blockbusters by 2025, finds report europeanpharmaceuticalreview
March 11, 2020
New research has found that of the drugs in the pre-registration phase, 10 are expected to become blockbusters over the next six years.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page